Allstate (NYSE:ALL) Price Target Raised to $173.00 at Evercore ISI

Allstate (NYSE:ALL) had its price objective raised by equities research analysts at Evercore ISI from $166.00 to $173.00 in a report released on Thursday, Benzinga reports. The brokerage presently has an “in-line” rating on the insurance provider’s stock. Evercore ISI’s target price points to a potential upside of 3.71% from the company’s current price.

A number of other research firms also recently weighed in on ALL. Wells Fargo & Company raised their price target on Allstate from $112.00 to $145.00 and gave the company an “underweight” rating in a research note on Friday, February 9th. TheStreet upgraded shares of Allstate from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. HSBC raised shares of Allstate from a “hold” rating to a “buy” rating and lifted their price objective for the company from $158.00 to $190.00 in a research report on Thursday, March 28th. JPMorgan Chase & Co. upped their target price on shares of Allstate from $172.00 to $185.00 and gave the company an “overweight” rating in a report on Monday, April 8th. Finally, Roth Mkm lifted their price target on Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a report on Monday, April 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $172.59.

Allstate Trading Up 0.7 %

NYSE ALL opened at $166.81 on Thursday. Allstate has a one year low of $100.57 and a one year high of $174.57. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.37 and a quick ratio of 0.37. The firm has a market cap of $43.88 billion, a P/E ratio of -134.52, a P/E/G ratio of 0.42 and a beta of 0.52. The stock’s 50-day moving average is $163.04 and its 200-day moving average is $145.13.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Thursday, February 8th. The insurance provider reported $5.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $1.95. The company had revenue of $14.83 billion during the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a negative net margin of 0.33% and a positive return on equity of 2.67%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($1.36) earnings per share. Sell-side analysts anticipate that Allstate will post 13.41 earnings per share for the current fiscal year.

Insider Transactions at Allstate

In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares in the company, valued at $1,712,069.92. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the sale, the insider now directly owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO John C. Pintozzi sold 4,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Allstate

A number of hedge funds have recently made changes to their positions in the stock. Sei Investments Co. grew its stake in shares of Allstate by 40.2% during the first quarter. Sei Investments Co. now owns 187,869 shares of the insurance provider’s stock worth $26,022,000 after buying an additional 53,824 shares during the last quarter. Prudential PLC bought a new stake in Allstate during the 1st quarter worth $1,325,000. Cetera Investment Advisers increased its holdings in Allstate by 13.9% in the 1st quarter. Cetera Investment Advisers now owns 23,536 shares of the insurance provider’s stock worth $3,260,000 after purchasing an additional 2,874 shares in the last quarter. Dakota Wealth Management bought a new position in Allstate in the first quarter valued at about $270,000. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of Allstate by 36.2% during the first quarter. Sequoia Financial Advisors LLC now owns 3,237 shares of the insurance provider’s stock valued at $448,000 after purchasing an additional 860 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.